Got $5,000? TransMedics Could Be a High‑Tech Organ Transplant Moonshot

TransMedics clarifies Q4 tax benefit impact on earnings

TransMedics Group (NASDAQ:TMDX) Shares Up 5.9% - What's Next?

TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results

TransMedics Stock Soars After Beating Revenue Expectations and Raising Guidance

A Look At TransMedics Group (TMDX) Valuation After Earnings Beat And Growth Guidance